Steel H C, Anderson R
Medical Research Council Unit for Inflammation and Immunity, Department of Immunology, Institute for Pathology, Faculty of Health Sciences, University of Pretoria, South Africa.
Clin Exp Immunol. 2004 May;136(2):255-61. doi: 10.1111/j.1365-2249.2004.02443.x.
We have investigated the effects of itraconazole (0.1-10 micro m), an antimycotic which is often used prophylactically in primary and secondary immunodeficiency disorders, including chronic granulomatous disease, on mobilization of Ca(2+) and restoration of Ca(2+) homeostasis following activation of neutrophils with FMLP or PAF. Transmembrane fluxes of Ca(2+), as well as cytosolic concentrations of the cation were measured using a combination of spectrofluorimetric and radiometric procedures. The abruptly occurring increases in cytosolic Ca(2+) following activation of the cells with either FMLP (1 micro m) or PAF (200 nm) were unaffected by itraconazole. However, the subsequent store-operated influx of the cation was attenuated by itraconazole at concentrations of 0.25 micro m and higher. The itraconazole-mediated inhibition of uptake of Ca(2+) was not associated with detectable alterations in the intracellular concentrations of cyclic AMP, ATP or inositol triphosphate, and appeared to be compatible with antagonism of store-operated Ca(2+) channels. Although a secondary property, this anti-inflammatory activity of itraconazole, if operative in vivo, may be beneficial in conditions associated with dysregulation of neutrophil Ca(2+) handling such as CGD.
我们研究了伊曲康唑(0.1 - 10微摩尔)的作用,伊曲康唑是一种抗真菌药,常用于原发性和继发性免疫缺陷疾病(包括慢性肉芽肿病)的预防,观察其对用N - 甲酰甲硫氨酰 - 亮氨酰 - 苯丙氨酸(FMLP)或血小板活化因子(PAF)激活中性粒细胞后钙离子动员及钙离子稳态恢复的影响。使用荧光分光光度法和放射性测量法相结合的方法,测定了钙离子的跨膜通量以及细胞溶质中阳离子的浓度。用FMLP(1微摩尔)或PAF(200纳米)激活细胞后,细胞溶质中钙离子的突然增加不受伊曲康唑影响。然而,随后阳离子的储存式流入在伊曲康唑浓度为0.25微摩尔及更高时受到抑制。伊曲康唑介导的钙离子摄取抑制与环磷酸腺苷、三磷酸腺苷或肌醇三磷酸的细胞内浓度的可检测变化无关,似乎与储存式钙离子通道的拮抗作用相符。尽管这是一种次要特性,但如果伊曲康唑的这种抗炎活性在体内起作用,可能对与中性粒细胞钙离子处理失调相关的疾病(如慢性肉芽肿病)有益。